George Locke

Statistics

Publications

Citations

1.1K

H-Index

Active since

2010

Affiliations

Rutgers, The State University of New Jersey(Current)

Quantitative BioSciences

Merck Serono S.p.A. (Italy)

Research & Development Institute

Ono Pharmaceutical (United States)

George Locke is an author at Rutgers, The State University of New Jersey specializing in life sciences, tumor immunology, and programmed death-ligand 1 inhibition.

ORCID

Publications per year

2010–2022

Publications

Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β

Yan Lan, Dong Zhang, Chunxiao Xu et al. · Science Translational Medicine · 2018 · 488 citations

Life Sciences, Immunology, Oncology +17

Design, calibration, and performance of the MINERvA detector

L. Aliaga, L. Bagby, B. Baldin et al. · Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment · 2014 · 211 citations · Full text

Engineering, Nuclear Engineering, Physics +17

Simultaneous targeting of TGF-β/PD-L1 synergizes with radiotherapy by reprogramming the tumor microenvironment to overcome immune evasion

Yan Lan, Mahmoud Moustafa, Maximilian Knoll et al. · Cancer Cell · 2021 · 190 citations · Full text

Medicine, Immunology, Oncology +17

High-throughput sequencing reveals a simple model of nucleosome energetics

George Locke, Denis Tolkunov, Zarmik Moqtaderi et al. · Proceedings of the National Academy of Sciences · 2010 · 70 citations · Full text

Life Sciences, Biophysics, Molecular Biology +17

Connective Tissue Growth Factor Domain 4 Amplifies Fibrotic Kidney Disease through Activation of LDL Receptor–Related Protein 6

Bryce G. Johnson, Shuyu Ren, Gamze Karaca et al. · Journal of the American Society of Nephrology · 2017 · 46 citations

Life Sciences, Cell Biology, Pathology +17

1–5 of 8